Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$42.05 - $47.77 $348,846 - $396,299
-8,296 Closed
0 $0
Q4 2021

Feb 04, 2022

SELL
$38.88 - $45.31 $57,348 - $66,832
-1,475 Reduced 15.1%
8,296 $366,000
Q3 2021

Nov 10, 2021

BUY
$38.79 - $43.16 $35,260 - $39,232
909 Added 10.26%
9,771 $373,000
Q2 2021

Aug 09, 2021

SELL
$36.52 - $41.46 $73,040 - $82,920
-2,000 Reduced 18.41%
8,862 $353,000
Q1 2021

May 10, 2021

SELL
$34.27 - $40.01 $47,463 - $55,413
-1,385 Reduced 11.31%
10,862 $388,000
Q4 2020

Feb 05, 2021

SELL
$34.07 - $39.94 $110,557 - $129,605
-3,245 Reduced 20.95%
12,247 $451,000
Q3 2020

Oct 29, 2020

BUY
$38.11 - $42.99 $2,667 - $3,009
70 Added 0.45%
15,492 $583,000
Q2 2020

Aug 07, 2020

SELL
$37.87 - $43.58 $51,124 - $58,833
-1,350 Reduced 8.05%
15,422 $629,000
Q1 2020

May 06, 2020

BUY
$32.47 - $48.83 $10,065 - $15,137
310 Added 1.88%
16,772 $635,000
Q4 2019

Jan 30, 2020

BUY
$42.0 - $48.25 $49,350 - $56,693
1,175 Added 7.69%
16,462 $774,000
Q3 2019

Nov 04, 2019

BUY
$40.46 - $43.52 $10,115 - $10,880
250 Added 1.66%
15,287 $652,000
Q2 2019

Jul 29, 2019

SELL
$39.4 - $42.7 $15,760 - $17,080
-400 Reduced 2.59%
15,037 $602,000
Q1 2019

Apr 29, 2019

SELL
$38.57 - $42.69 $15,428 - $17,076
-400 Reduced 2.53%
15,437 $645,000
Q4 2018

Jan 28, 2019

SELL
$37.8 - $42.69 $7,559 - $8,538
-200 Reduced 1.25%
15,837 $605,000
Q3 2018

Nov 08, 2018

SELL
$39.75 - $42.69 $155,025 - $166,491
-3,900 Reduced 19.56%
16,037 $644,000
Q4 2017

Feb 06, 2018

SELL
$35.34 - $41.9 $217,341 - $257,685
-6,150 Reduced 23.57%
19,937 $707,000
Q3 2017

Nov 06, 2017

SELL
$39.44 - $41.55 $185,368 - $195,285
-4,700 Reduced 15.27%
26,087 $1.06 Million
Q2 2017

Aug 08, 2017

BUY
N/A
30,787
30,787 $1.33 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $68.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Ntv Asset Management LLC Portfolio

Follow Ntv Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ntv Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ntv Asset Management LLC with notifications on news.